‘IIT Mandi has given me growth, self-discovery, and friendships that will last a lifetime'
I am a fourth-year undergraduate student in the Bioengineering branch of the Department of Biosciences and Bioengineering at the Indian Institute of Technology (IIT) Mandi. I come from Lucknow, but my roots in this journey began in Kanpur, where I studied till Class 10 at KDMA International. I then completed my Class 12 from Lucknow Public School.
From an early age, biology always fascinated me – probably because of my father, who is a veterinary doctor. Watching him work sparked a curiosity in life sciences, while my exposure to Artificial Intelligence and Data Science during my JEE preparation deepened my interest in blending biology with computation. These interests came together in the form of Bioengineering, a field I am lucky to now be pursuing at IIT Mandi.
I first appeared for JEE Main and JEE Advanced right after my Class 12 in 2021, but the results didn't meet my expectations. So, I took a drop year and reappeared for JEE in 2022. During that drop year, I prepared on my own using online resources, standard books, and mock tests. It wasn't easy – many of us isolate ourselves from social life, miss birthdays, celebrations, and even our hobbies. But I now tell aspirants that they should not cut themselves off completely. These moments won't come back. Balance is key. As the saying goes, 'Success is important, but so is the journey. Don't lose yourself while chasing your dreams.'
Coming to IIT Mandi in November 2022 was my first time living away from home. Initially, I missed the homemade food, my old friends, and my younger sister, whom I am really close to. But everything changed once I found my tribe here, friends including Ayush, Aryan, Vishal, Dhruv, Harsh, Vivek, Vibhu, and Shreyansh. My first semester became one of the most memorable times of my life – late-night project building, hackathons, competitions, and shared laughter.
Campus life here is different from other colleges, and not just because it is nestled in the Himalayas, it is the people that make it special. The peer group you find in an IIT inspires you in countless ways. When someone in your circle goes for an internship, course, or competition, it pushes you to think, 'Hey, maybe I can do that too.'
Outside academics, I got involved in several clubs – drama, design, Sysadmin, and the Kamand Bioengineering Club. These clubs allowed me to explore areas I'd never tried before and contributed to my personal development. It wasn't easy balancing academics and club work, but the environment here teaches you to manage your time and push your boundaries.
The professors here are incredibly supportive. One moment I'll always remember is when our Japanese teacher joined us in a student-organised 'Glow in the Dark' paint-art event. That role reversal, where we were the teachers and she was the student, was unforgettable. Another moment that stuck with me was when I missed the campus bus and a professor offered me a lift to the academic block – it was a small gesture, but it truly showed how approachable and kind the teachers are.
Life at IIT has transformed me mentally, spiritually, and emotionally. I have learned leadership, time management, teamwork, and resilience. But perhaps the most important lesson I have learned here is that everyone is confused.
It might seem like some people have it all figured out, but most of us are just trying to find our path. So, once in a while, ask yourself if you enjoy what you're doing. If the answer is 'somewhat yes', keep going. Try out different things – because you don't want to leave college with regrets.
In my second year, I participated in the Inter IIT Cultural Meet as part of the Dramatics Club in 'Nukkad Natak', and we secured the second-highest score. Later, I led our contingent, coordinating teams, managing logistics, and learning leadership in a high-pressure but fun environment.
My typical day involves morning classes, lab work, and assignments. Evenings are for friends, club events, or walks. I don't play any sport, but I do enjoy watching anime and movies, and going on treks around the beautiful hills that surround us. We hang out at the Village Square, the hostel rooms, play foosball or table tennis, and snack at campus canteens. My favourite food to binge on here is siddu, a local Himachali dish.
I support my expenses partly through teaching assistant roles and partly through pocket money from my parents. And while I love the serenity of our hilltop campus, I sometimes miss the buzz of city life – malls, cinemas, and amusement parks.
Looking ahead, I see myself going for higher studies, possibly in Computational Biology, Genomics, or Neuroscience.
The culture, the food, and the rich history of Lucknow are close to my heart – and yes, I do miss them. But what I miss most is my sister and those late-night food outings. Still, if I had to sum it all up, I'd say that this journey at IIT Mandi has been one of growth, self-discovery, and friendships that will last a lifetime.
Mridusmita Deka covers education and has worked with the Careers360 previously. She is an alumnus of Gauhati University and Dibrugarh University. ... Read More
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
7 hours ago
- Indian Express
IIT Madras to offer mentorship, support to students admitted through FACE, ScOpE
The Indian Institute of Technology Madras (IIT Madras) has admitted nine students to its BTech programmes through the Fine Arts and Culture Excellence (FACE) admissions scheme for the first time this year. Under the scheme, two seats per programme are allotted in all BTech and BS courses – one reserved for female candidates and the other gender-neutral. The objective of FACE admission is to reward and encourage students who have achieved excellence in fine arts and culture. Candidates who opted to be treated at par with Indian nationals during JEE Advanced 2025 registration were eligible for FACE admission and had to apply via the dedicated portal – Alongside FACE, the institute runs the 'Science Olympiad Excellence' (ScOpE) scheme and had earlier introduced the Sports Excellence Admission (SEA) from the 2024-25 academic year, becoming the first IIT to offer a dedicated pathway for sports persons. SEA requires students to qualify JEE Advanced, however, admissions are handled through a separate IIT Madras portal, instead of the JoSAA system. These admissions are offered through supernumerary seats, ensuring that the overall intake via JEE Advanced remains unchanged. Students admitted to IIT Madras through ScOPE, who are often academically inclined, receive guidance under the institute's regular faculty advisor scheme at the institute. For the newly joined FACE students this year, a mentorship structure similar to that for sports excellence admissions has been designed, focusing on nurturing their talents and encouraging participation in relevant programmes and competitions, the institute said. 'Support to nurture their talents will be enabled and they will be encouraged to participate in suitable programmes and competitions,' the was told. The initiatives have drawn positive responses from parents, with several appreciating the alternative routes to IIT Madras for students excelling in sports, fine arts, or Olympiads. As these schemes are only in their first and second year respectively, their wider impact is still taking shape.
Hans India
15 hours ago
- Hans India
IIT Delhi's new method to cut textile waste, recycle discarded denims to good quality garments
New Delhi: A team of researchers from IIT Delhi has developed a new method to recycle denim waste to knitted garments without compromising quality. The findings will also help reduce textile waste -- the discarded textiles and clothing after their use -- which end up in landfills. India accumulates around 3.9 million tonnes of domestic post-consumer textile waste annually, of which only 4 per cent is recycled. Those recycled lose fibre strength and face variability in colour and quality. However, with the novel method, the IIT researchers found that up to 50 per cent of recycled yarns can be used in knitted clothing without deteriorating the feel of the product. 'To reduce the roughness of recycled yarns, a softening treatment was applied to the fabric, which ensured that the tactile feel of the final product is the same as that of virgin products, said Prof Abhijit Majumdar, Dept. of Textiles and Fibre Engineering, IIT Delhi. 'We have demonstrated our work with denim waste, and it can be extended with any other textile waste,' he added. In the study, detailed in the Journal of Cleaner Production, the team recycled waste denim into yarns, ensuring minimum damage to the fibre properties by optimising the process conditions. Recycled yarns were then blended into knitted fabric using the seamless whole garment technology. Knitted garments were produced, varying the recycled yarn content from 25 per cent to 75 per cent. Another key aspect of this research was to quantify the environmental benefits through life cycle assessment (LCA) in the Indian context. Analysis by the IIT Delhi team showed that around 30-40 per cent of environmental impacts can be mitigated in terms of greenhouse gas emission, acid rain, and fossil fuel depletion, whereas for ozone layer depletion, it is around 60 per cent. As the use of recycled fibres could reduce the use of virgin cotton, the pesticides, fertilisers and water used for cultivation can also be saved. Among the processes involved, the cotton cultivation stage itself contributes 24 per cent to global warming, making the virgin yarns less environment-friendly. 'The research team is now exploring the possibility of recycling textile waste materials multiple times,' added Prof B.S. Butola, Dept. of Textile and Fibre Engineering, IIT Delhi.
The Hindu
18 hours ago
- The Hindu
Landmark study offers new insights into what protects against dengue
The specific components of the immune response in a human body that protect against a dengue virus (DENV) infection and the subsequent illness remain unclear. Scientists are still trying to understand how natural infection and vaccination protect people so that they can develop better vaccines. Now, a novel study has revealed important insights into developing strong immunity against DENV, which is otherwise quite complex. Researchers from the US and Philippines have identified specific antibodies, known as envelope dimer epitope (EDE)-like antibodies, as the key for building broad, cross-serotype immunity following natural infection or vaccination. The findings, published recently in Science Translational Medicine, represent a significant step forward in understanding dengue immunity and could lead to more effective therapeutics. Disease burden and dengue vaccines Dengue is a major global health challenge caused by any of four DENV serotypes (DENV1 to DENV4). It is the most common vector-borne viral disease, with half of the world's population at risk, especially in Southeast Asia, Africa, and the Americas. According to one large study in 2013, the economic burden of dengue in Southeast Asia is higher than that of 17 other conditions, including Japanese encephalitis, upper respiratory infections, and hepatitis B. And yet developing a universally effective vaccine has proven difficult thanks to the complex immune mechanisms involved. In DENV cases, the initial immunity after first infection (a.k.a. primary immunity) paradoxically increases the risk of severe disease rather than conferring protection when a person is infected a second time with a different serotype of the virus. This phenomenon, called antibody-dependent enhancement, occurs when non-neutralising antibodies bind to partially immature virus particles, facilitating their entry into immune cells and worsening the infection. All severe dengue cases requiring hospitalization result from such second infections. Since vaccines mimic natural infections, the risk of antibody-dependent enhancement after the first dose is the main challenge for dengue vaccines, which is why they are usually recommended only for individuals with prior exposure to the virus and avoided in dengue-naïve people. After exposure to at least two different DENV serotypes, a person develops true protection, known as 'secondary immunity', against future disease. Currently, two primary dengue vaccines are licensed (in some countries): Dengvaxia and QDENGA. These shots are most effective for individuals who have already been exposed to dengue at least once before vaccination. Laboratory confirmation of a previous dengue infection is required for vaccination with Dengvaxia. Outbreak in Cebu DENV is an enveloped virus, meaning it has a protective outer layer. A key component of this layer is the envelope (E) protein, which is the primary target for the body's immune response. The E protein is arranged in pairs on the virus surface, creating complex three-dimensional structures known as quaternary epitopes. EDE is a critical quaternary epitope and an important target for vaccines and therapeutic antibodies. In June 2017, Cebu province in the Philippines offered at least the first dose of a dengue vaccine to children aged 9-14 years. For the new study, the researchers recruited and followed a cohort of 2,996 such children. Of them, 1,782 received the first dose of the vaccine and the rest remained unvaccinated. The researchers collected baseline blood samples one month before the vaccination campaign and follow-up samples 17-28 months after the campaign. There had been an unusually large dengue outbreak in Cebu between the baseline and follow-up sample collection, with most cases caused by DENV2 (61.7%) followed by DENV3 (30%). The researchers measured different kinds of antibodies in the samples: EDE-like antibodies (targetting envelope dimer epitopes); neutralising antibodies (which can block infection by mature, fully formed viruses); and binding antibodies (those that attached to parts of the E protein without necessarily blocking infection). The study focused on the children who had had evidence of at least two prior DENV infections (those with 'secondary immunity') at the baseline. They followed up with the cohort up to October 31, 2022, to check how many with secondary immunity went on to develop dengue between the follow-up sample collection and the study closure date. All the samples were analysed in vaccinated and unvaccinated children in this subgroup in an attempt to reveal the true predictors of protection. More protective against disease The study's findings illuminated the role of EDE-like antibodies in the protective response. Specifically, the researchers found that EDE-like antibodies were highly prevalent in children with secondary DENV immunity, with 81.8% to 90.1% of participants having detectable levels. This was in stark contrast to individuals with only primary DENV immunity, where EDE-like antibodies were largely absent (detected in only 4% to 12% of cases). This suggests EDE-like antibodies are a hallmark of established immunity against dengue. The magnitude of EDE-like antibodies was also strongly and consistently correlated with broad neutralisation of all four mature DENV serotypes, indicating that these antibodies are crucial for widespread protection rather than just against a single serotype. The study observed that both natural DENV infection — due to the large outbreak during the study period — and vaccination significantly boosted EDE-like antibodies as well as general DENV-binding and neutralising antibodies. This effect was evident even in children who already possessed strong secondary immunity. Crucially, higher levels of EDE-like antibodies were consistently associated with lower odds of symptomatic dengue, dengue with warning signs, and dengue requiring hospitalisation. This protective effect was observed across multiple serotypes, demonstrating both serotype-specific and cross-reactive benefits. However, EDE-like antibodies had limited protective effects against viral replication. Thus, they were less protective against new infections but more protective against disease, especially severe disease. Perhaps the most significant finding was that EDE-like antibodies didn't just correlate with protection: they statistically explained a substantial portion of the protective effect seen with other mature virus-neutralising and E-binding antibodies. That is, when EDE-like antibodies were factored into statistical models, the protective effect of other antibodies was significantly diminished while EDE-like antibodies remained strongly associated with protection. Specifically, EDE-like antibodies explained 42% to 65% of the protective effect attributed to mature virus-neutralising antibodies and 41% to 75% of the effect of general E protein-binding antibodies. This observation strongly suggested that EDE-like antibodies are a primary, underlying determinant of broad, cross-reactive immunity against dengue. Limitations and the future Although the study had some limitations, such as a relatively small number of dengue cases for assessing protection against all four serotypes and a limited panel of monoclonal antibodies used for characterisation, it nonetheless marked a significant advance in the fight against dengue. The team provided a clearer understanding of the immune responses that truly protect against this debilitating disease. EDE-like antibodies also helped explain how neutralising and binding antibodies contributed to protection. Further research will be essential to formally validate EDE-like antibodies as reliable indicators of protection for vaccine efficacy trials. If this is validated, researchers will be able to design vaccines that specifically elicit high levels of EDE-like antibodies and thus better protect against dengue. Puneet Kumar is a clinician, Kumar Child Clinic, New Delhi. Vipin M. Vashishtha is director and paediatrician, Mangla Hospital and Research Center, Bijnor.
